Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07271771 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity

Study acronym: DENMUSIN
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Collaborators expanded, about 8 wordsv2 See this version in full on ClinicalTrials.gov ↗
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Randomized, placebo controlled prospective trial evaluating the effect of denosumab on insulin sensitivity and muscle strength.
Trial Details
NCT Number NCT07271771
Lead Sponsor Aarhus University Hospital
Collaborators: Sponsor: MD, Professor, DMSc, PhD Bente Lomholt Langdahl
Conditions Osteoporosis
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov